北京今年拟首批投入超15亿元促高精尖产业发展 中新社北京1月22日电 (记者 吕少威)北京市经济和信息化局副局长刘维亮在22日举行的新闻发布会上表 示，该局编制了2026年第一批高精尖产业发展项目资金和支持中小企业发展资金实施指南(下称"实施指 南")，拟发布不少于25个政策支持方向，计划投入资金超15亿元(人民币，下同)。 据介绍，实施指南支持领域涵盖集成电路、生物医药、材料能源、信息软件、数字经济等十余个重点产 业。 根据实施指南，在促进创新方面，北京鼓励为机器人、集成电路、新材料等领域创新产品提供市场验证 机会，支持机器人应用方案在国内工厂、商超、物流、农业等场景实现首次试用；支持先进基础和关键 战略材料、生物材料、航空航天材料等新材料首批次示范应用；支持商业航天企业为星箭发射和在轨运 营购买财产险、三者险、在轨险，缓释创新风险。 来源：中国新闻网 编辑：熊思怡 广告等商务合作，请点击这里 本文为转载内容，授权事宜请联系原著作权人 中新经纬版权所有，未经书面授权，任何单位及个人不得转载、摘编或以其它方式使用。 关注中新经纬微信公众号(微信搜索"中新经纬"或"jwview")，看更多精彩财经资讯。 在促进 ...

Core Viewpoint - The company is collaborating with the Guangdong-Hong Kong-Macao Greater Bay Area Huangpu Materials Research Institute to establish Guangzhou Jitian New Materials Co., Ltd. for the development and production of domestic aircraft windshield adhesive, which is currently in the research and industrialization preparation stage and has not yet entered commercial use [2] Group 1 - The company announced the establishment of Guangzhou Jitian New Materials Co., Ltd. in May 2025 [2] - The joint venture aims to promote the research and production of domestic aircraft windshield adhesive [2] - The related products are still in the research and industrialization preparation phase and have not yet been commercialized [2]

Group 1 - The company, Xinbo Co., Ltd. (003038.SZ), announced a collaboration with Weichu New Materials, Anhui Weichu, and Zhongxin Technology to jointly invest 30 million yuan in establishing Chuzhou Xinbo Alloy Materials Research Institute Co., Ltd. [1] - Xinbo Co., Ltd. will contribute 24.6 million yuan, accounting for 82% of the total investment in the research institute [1]. - The research institute aims to focus on the research and development of alloy materials, technology transfer, and related businesses, targeting six core areas to provide higher quality products for the new energy vehicle and new energy photovoltaic sectors [1].

Core Insights - The article highlights the role of technology brokers in transforming technological achievements into practical applications, with a focus on the contributions of Deng Guoyong, the chairman of Maiju Technology Group and founder of Maiju Network [1][5]. Group 1: Deng Guoyong's Background and Expertise - Deng Guoyong's journey as a technology broker is rooted in over 20 years of cross-industry experience, starting from grassroots positions to becoming a multi-field expert [2][3]. - His practical experience spans various sectors, including waterproofing, real estate, and internet entrepreneurship, allowing him to accumulate valuable insights into technology application [2][5]. Group 2: Achievements and Contributions - In September 2025, Deng Guoyong obtained the national technology broker qualification, marking a new beginning that integrates his industry experience with technology transfer knowledge [5]. - Deng emphasizes that the core of technology brokering is not merely matchmaking but ensuring that technology creates real value, leading to successful technology transfer practices across multiple fields [5][6]. Group 3: Impact on Rural Revitalization and Employment - In rural revitalization, Deng employs technology brokerage to promote the integration of digital technologies with agricultural practices, exemplified by the development of a "zero-worker station" app that addresses employment needs [6][12]. - This initiative has been recognized as a highlight project in Hebei Province, directly benefiting thousands of farmers by providing flexible employment opportunities [6][12]. Group 4: Team Development and Collaborative Efforts - Under Deng's leadership, the core team at Maiju Technology has also achieved technology broker qualifications, creating a team proficient in technology, market understanding, and integration [11]. - The team has successfully integrated over 10,000 pieces of information related to research outcomes and enterprise technology needs, facilitating numerous technology cooperation projects [11]. Group 5: Social Responsibility and Community Focus - Deng's approach to technology brokerage is characterized by a commitment to social responsibility, focusing on projects that enhance the livelihoods of individuals and communities [12]. - Initiatives include providing free technical consulting services to small and micro enterprises, ensuring that technology brokerage is accessible beyond large corporations [12].

Investment Rating - The investment rating for the company is "Buy" (maintained) [6] Core Views - The company's performance in the first three quarters of 2025 met expectations, with total revenue of 34.854 billion yuan, a year-on-year increase of 3.5%, and a net profit attributable to shareholders of 3.209 billion yuan, a year-on-year increase of 31.3% [6] - The offshore oil service industry remains at a high level of prosperity, with the company's drilling platform operating days reaching 14,784 days, a year-on-year increase of 12.3% [6] - The company is focusing on enhancing its core technology system driven by fundamental research, which is expected to lead to stable growth in its oilfield technical services segment [6] - The company's capital expenditure remains high, with China National Offshore Oil Corporation (CNOOC) planning capital expenditures of 125 to 135 billion yuan for 2025, providing a solid order guarantee for the company [6] - The profit forecasts for 2025 and 2026 have been raised to 3.98 billion yuan and 4.7 billion yuan respectively, maintaining the 2027 profit forecast at 5.36 billion yuan, corresponding to price-to-earnings ratios of 17X, 15X, and 13X [6] Financial Data and Profit Forecast - Total revenue for 2025 is estimated at 51.233 billion yuan, with a year-on-year growth rate of 6.1% [5] - The net profit attributable to shareholders for 2025 is projected to be 3.98 billion yuan, reflecting a year-on-year growth rate of 26.9% [5] - The earnings per share for 2025 is expected to be 0.83 yuan [5] - The gross profit margin for 2025 is estimated at 17.2% [5] - The return on equity (ROE) for 2025 is projected to be 8.5% [5]

Core Insights - Fuxiang Pharmaceutical reported a revenue of 769 million yuan for the first three quarters of 2025, focusing on the synergistic development of its three core businesses: pharmaceutical manufacturing, new energy lithium battery materials, and synthetic biological microbial proteins [1] R&D Foundation - In the pharmaceutical manufacturing sector, the company is enhancing product potential through green alternatives and process optimizations, leading to a continuous decrease in production costs [2] - The company has achieved a production capacity of 8,000 tons of vinyl carbonate (VC) and 3,700 tons of fluorinated ethylene carbonate (FEC) in its new energy segment, benefiting from a recovering market for electrolyte additives, with prices rising over 20% month-on-month [2] Marketing Expansion - Fuxiang Pharmaceutical is strengthening strategic partnerships with core customers and expanding into international markets, particularly in the synthetic biological microbial protein sector [4] - The establishment of the Weiran Alliance in Shanghai aims to commercialize new protein products and has attracted several international brands as initial members [4] International Market Development - The company has secured a patent in South Korea for its application of short-handled fungus in producing mycelium protein, laying a solid foundation for entering the East Asian market [5] - Fuxiang Pharmaceutical has established a subsidiary in Singapore to focus on the development and sales of microbial protein consumer products, accelerating its overseas market expansion [5][6] Future Outlook - The company plans to continue investing in R&D innovation, enhancing marketing networks, and deepening collaborative innovation with strategic partners to activate new growth momentum [6]

Core Insights - The article discusses the differences between the ChiNext Index and the Sci-Tech 50 Index, highlighting their unique roles in China's capital market and technology sector [1][2]. Group 1: Growth Characteristics - The ChiNext Index, established in 2009, has evolved from a platform for internet service companies to a benchmark for various sectors including new energy, high-end equipment, and biomedicine, representing a "versatile expert" in China's new economy [1][2]. - The Sci-Tech 50 Index, launched in 2019, focuses on key technology areas such as semiconductors, AI, and biomedicine, embodying a "hardcore pioneer" with a strong emphasis on technological breakthroughs [2]. Group 2: Investment Logic - Investment in the ChiNext Index is driven by the potential for high growth in established sectors, with a focus on revenue and net profit growth, and a current TTM PE ratio of approximately 44 times, indicating a reasonable valuation [3][4]. - For the Sci-Tech 50 Index, investors should prioritize the potential for technology commercialization and the intensity of R&D investment, with a TTM PE ratio of 180 times, but a projected net profit compound annual growth rate of nearly 50% from 2025 to 2027 [4]. Group 3: Index Investment Strategy - Index investing provides a safer approach for ordinary investors, mitigating risks associated with rapid technological changes and individual stock volatility [6][7]. - By diversifying investments across both the ChiNext and Sci-Tech 50 indices, investors can benefit from different growth cycles and reduce the impact of sector rotation [7][8]. Group 4: Conclusion - The ChiNext ETF and Sci-Tech 50 ETF represent complementary investment opportunities, allowing investors to participate in China's technological growth while lowering the barriers to entry [8].

Core Insights - The Victory Oilfield Ground Engineering Maintenance Center emphasizes technological innovation and efficient transformation of technological achievements into new productive forces [1][2] - The center focuses on a "technology + management" approach to enhance the application of new technologies [1] Group 1: Technological Innovation - The center has established specialized analysis teams and databases for pipeline zero leakage, pipeline operation optimization, and pump station efficiency [1] - A strategy of "application generation, reserve generation, and research generation" is adopted, concentrating on four technology categories: pipelines, tanks, pumps, and information technology [1] - Key technological challenges include automatic welding, repair tool modification, and pump accessory restoration materials [1] Group 2: Service Model Enhancement - The Kehkou Maintenance Service Department has upgraded traditional hoisting to a "one-stop" service model that includes disassembly, hoisting, transportation, and installation [2] - The center has implemented a "1+N" mechanism for collaborative efforts, promoting "zero fire" and "zero leakage" demonstration zone construction [2] - The Victory North Maintenance Service Department has established a rapid response and resource allocation mechanism, improving fault handling efficiency by 30% [2] Group 3: Management and Competitive Edge - The center is enhancing management and competitiveness through multi-dimensional strategies [2] - The Binzhou Maintenance Service Department is cultivating "zero fire" demonstration zones by implementing a three-dimensional attack network [2] - The Binhai Pump Repair Service Department has developed a compliance operating mechanism, achieving full-process risk warning through a comprehensive compliance system [2]

Group 1 - Jiangsu Modern Road and Bridge Co., Ltd. focuses on green and low-carbon development through innovative research such as "solid waste-based foam lightweight soil" [1] - The company has established a supportive environment for postdoctoral researchers, providing competitive salaries, advanced research facilities, and various subsidies from both the company and the Nanjing government [1][2] - Nanjing has implemented the "Ningju Project" to attract and support postdoctoral talent, with 428 postdoctoral platforms established and approximately 1,500 postdoctoral researchers recruited in the past three years [2][3] Group 2 - Postdoctoral talents are seen as crucial for driving technological transformation and industrial upgrading, with significant contributions to new materials and technologies [4] - Jiangsu Modern Road and Bridge has achieved nearly 50 million yuan in results transformation from over 20 new materials and technologies developed by postdoctoral teams [4] - The company has received 18 provincial and ministerial awards and holds multiple patents, showcasing the impact of postdoctoral research on innovation [4] Group 3 - Nanjing provides comprehensive support for postdoctoral researchers, including financial subsidies, job evaluation green channels, and family services, enhancing their living conditions [5] - The first Nanjing Postdoctoral Innovation and Entrepreneurship Competition has stimulated research and entrepreneurial enthusiasm among postdoctoral researchers [5] - Nanjing is actively organizing job fairs and talent exchange events to connect high-level postdoctoral candidates with opportunities, further solidifying its reputation as a nurturing environment for talent [5]

Core Insights - The article emphasizes the collaboration between doctors, CEOs, engineers, and investors to address challenges in medical device innovation through a workshop organized by Shanghai Jiao Tong University [1][5]. Course Highlights - The workshop aims to merge medical pain points with engineering technology to create innovative medical products and facilitate results transformation [5]. - Participants will learn the complete path from concept to market for medical devices, addressing the common issue of collaboration between medical professionals and engineering teams [5]. Target Audience - The program is suitable for various professionals including doctors, medical technicians, engineering personnel from research institutions, industry practitioners, investors, and entrepreneurs interested in medical device innovation [6][10]. Training Information - The workshop will take place over two days on August 16-17, 2025, at Shanghai Jiao Tong University [6][10]. - The fee for participation is 8999 yuan per person, which includes course materials and refreshments, while accommodation is self-arranged [10]. Course Structure - The first day focuses on medical innovation and technology layout, including practical exercises and team drills to foster interdisciplinary communication [7][9]. - The second day will cover innovation commercialization and team building, emphasizing key points in medical engineering innovation and funding sources [13][16]. Expert Faculty - The faculty includes leading experts from Shanghai Jiao Tong University with extensive experience in medical technology and investment, providing insights into successful case studies and best practices in medical innovation [14][17]. Additional Opportunities - Participants will have the chance to network with industry experts, showcase their projects, and explore potential investment and collaboration opportunities [6][11].